|
Cancer Incidence
- Cancer ranks as the second most common cause of
death in the United States with an estimate by the
American Cancer Society of about 1.5 million new cases
of invasive cancer, based on an estimate for 2007.
Associated with this timeframe would be at death toll of
about a half million.1
- Over a lifetime, some type of invasive cancer would
likely affect almost 50% of men and about 35% of
women.
- The National Cancer Institute (NCI) maintains a
program designed to provide cancer statistics for the US
population. The studies are referred to as
SEER (Surveillance Epidemiology and End Results).
Updating the information above, the SEER database
indicates for 2008 about 1.4 7 million men and women
(about 745,000 men and 692,000 women) will be diagnosed
with an associated 565,000 deaths of cancer of all
sites.2 The data for estimated new cancer cases and
deaths for 2008 is described in more detail. (click
here)
- SEER database results indicate certain specific
probabilities are developing particular types of cancer. For
example, women have about a 12.5% lifetime chance of developing
breast cancer with men having a slightly higher likelihood of
developing prostatic cancer (16%).1,2
- The following cancers are responsible for about half of both
new diagnoses and cancer deaths in the United States:1
- lung cancer; lung cancer represents the leading cause of
death from cancer in the United States. This finding corresponds
to about 33% of deaths in men and women
- prostate cancer
- breast cancer
- colon and rectal cancer
- Lifetime risks (risk of diagnosis % and risk of death %) for
some cancers and for overall disease (bars on right side) are
described below:
Lifetime Risks (of diagnosis and death) for Some
Cancers and for Overall Disease3
|
 |
Incidence and Mortality of the 10 Cancers most common
in the U.S. for Malesd
|
Rank |
Men |
Incidencea |
Mortalitya |
| 1 |
Prostate |
178 |
30 |
| 2 |
Lung |
82 |
76 |
| 3 |
Colorectal |
63 |
25 |
| 4 |
Bladder |
38 |
8 |
| 5 |
Non-Hodgkin's
lymphoma |
24 |
10 |
| 6 |
Melanoma |
23 |
4 |
| 7 |
Oral cavity/pharynxc |
16 |
4 |
| 8 |
Kidney |
17 |
6 |
| 9 |
Leukemiasb |
16 |
10 |
| 10 |
Pancreas |
13 |
12 |
|
a Rates per 100,000 (1998-2002,
age adjusted using year 2000 U.S. census data with 5-year
grouping
b All leukemia
subtypes included: [Major subtypes include: ALL (acute
lymphoblastic leukemia), AML (acute myelogenous leukemia),
CLL (chronic lymphocytic leukemia), and CML (chronic
myelogenous leukemia]
c
Includes both larynx and oropharynx
d
SEER database (NCI SEER program; Ries LAD et al (eds):
SEER Cancer Statistics Review, 1975-2002, NCI, 2005 and
reference 1. |
Incidence and Mortality of the 10 Cancers
most common in the U.S. for Femalesd
|
Rank |
Women |
Incidencea |
Mortalitya |
| 1 |
Breast |
137 |
26 |
| 2 |
Lung |
51 |
41 |
| 3 |
Colorectal |
47 |
17 |
| 4 |
Uterus |
33 |
7 |
| 5 |
Ovary |
14 |
9 |
| 6 |
Non-Hodgkin's Lymphoma |
16 |
7 |
| 7 |
Melanoma |
15 |
2 |
| 8 |
Thyroid |
11 |
0.5 |
| 9 |
Pancreas |
10 |
9 |
| 10 |
Leukemiab |
10 |
6 |
|
a Rates per 100,000
(1998-2002, age adjusted using year 2000 U.S. census
data with 5-year grouping
b All
leukemia subtypes included: [Major subtypes include: ALL
(acute lymphoblastic leukemia), AML (acute myelogenous
leukemia), CLL (chronic lymphocytic leukemia), and CML
(chronic myelogenous leukemia]
c
Uterus classification is inclusive of both cervix and
corpus luteri
d
SEER database (NCI SEER program; Ries LAD et al (eds):
SEER Cancer Statistics Review, 1975-2002, NCI, 2005 and
reference 1. |
-
There
are many risk factors for the development of cancer; however,
the most important risk factor is age. Over 75% of cancers are
diagnosed in individuals who are 75 years or older. From a
population point of view, in the United States, with an aging
population, it is likely that the incidence of cancer will
increase. For example, by midcentury the number of cases may
double, increasing from 1.3 million to about 2.6 million cases a
year.
-
Again in
the United States, cancer incidence has remained relatively
constant while cancer-related deaths have tended to decrease
about 1% per year (1995-2002). When considering racial and
ethnic factors, this reduction in cancer-related mortality is
uneven.1
-
African American patients exhibit higher rates of
cancer-deaths even in those cancers for which the incidence
in the black population is less than observed in the white
population. Furthermore, five-year survival rates are
reduced stage-for-stage.1
-
Possible explanations for this discrepancy:1
-
Differences in cancer therapy
-
Presence of comorbid pathologies
-
Important variations in cancer biology
-
Furthermore, factors contributing to
racial disparities with respect to mortality can vary
with different cancers. There can be differences in the
extent of exposure to the contributing risk factors.
These differences might include, for instance, extent of
Helicobacter pylori in the case of stomach cancer,
prompt diagnosis and treatment (applies to many cancers)
as well as access to professional screening a regular
basis (cervical, breast, and colorectal cancers). The
example of higher breast cancer incidence among white
women could be accounted for by more frequent
mammography as well as factors that influence intrinsic
disease risk such as later age of first birth as well as
a higher degree of hormone replacement therapy use in
white women compared to African-American women. The
issue of higher stomach and liver cancer incidence and
death rates (by a factor of two) in Asian
American/Pacific Islanders relative to whites may be due
to increased exposure to hepatitis B and Helicobacter
pylori. Annual age-adjusted cancer death rates for
males for several cancers are described below.
Annual Age-adjusted Cancer Death Rates Among Men
(Selected Cancers)5
|
 |
These rates are
age-adjusted to the 2000 US standard
population. The information is
obtained from the US Mortality
Public Use Data Tapes, 1960-2003, US
Mortality Volumes, 1930-1959,
National Center for Health
Statistics, Centers for Disease
Control and Prevention, 2006.
Annual Age-adjusted Cancer Death Rates Among Females
(Selected Cancers)5
|
 |
Rates are age-adjusted to the 2000 US
standard population with the following
notations:
† the uterus classification includes
uterine cervix and uterine corpus.
The information is obtained from the US
Mortality Public Use Data Tapes,
1960-2003, US Mortality Volumes,
1930-1959, National Center for Health
Statistics, Centers for Disease Control
and Prevention, 2006.
-
Cancer rates are higher for whites and blacks
relative to Asians/Pacific Islanders. Considering prostate
cancer, the incidence among black men is 150% higher, compared
to whites, and 270% higher compared to Asian/Pacific Islanders.
1
-
On the other hand, white women exhibit a
120% higher breast cancer incidence relative to black women
and 170% higher incidence compared to Asians/Pacific
Islanders.
-
Other examples of racial differences include
higher rates of multiple myeloma in black men and women as
well as a higher rate of liver, intrahepatic bile duct, and
stomach cancer in Asians/Pacific Islander men and women.1
-
More detailed information concerning differences
between white and black patients overall and with respect to
five-year survival rates associated with different cancer sites
and race is presented in the following graphs developed in the
SEER program.
SEER Incidence:
All Cancer Combined by Race and Sex2,4
|
 |
Incidence rates are derived from SEER 17 areas
(San Francisco, Connecticut, Detroit, Hawaii,
Iowa, New Mexico, Seattle, Utah, Atlanta, San
Jose-Monterey, Los Angeles, Alaska Native
Registry, Rural Georgia, California excluding
SF/SJM/LA, Kentucky, Louisiana, and New Jersey)
and these rates are age-adjusted in accordance
with the 2000 US Census using 19 age groups.
5-Year Survival Rates Comparing White and Black
Patients, both Sexes, based on SEER data collected from
1996-20042,4
|
 |
Case data were obtained from SEER 17 areas: (San
Francisco, Connecticut, Detroit, Hawaii, Iowa,
New Mexico, Seattle, Utah, Atlanta, San
Jose-Monterey, Los Angeles, Alaska Native
Registry, Rural Georgia, California excluding
SF/SJM/LA, Kentucky, Louisiana, and New Jersey).
California with the above California-state
exclusions, Kentucky, Louisiana, and New Jersey
contributed cases for this analysis for
diagnostic years 2000-2004, whereas the
remaining 13 SEER areas contributed cases for
the entire 1996-2004 timeframe.
SEER Cancer Incidence and US Death Rates based on
data compiled between 2001-2005 by Cancer Site and Race2,4
|
Incidence (red) |
Cancer Site |
Mortality (blue) |
|
 |
Information for this table was obtained from SEER 17
areas: (San Francisco, Connecticut, Detroit, Hawaii,
Iowa, New Mexico, Seattle, Utah, Atlanta, San
Jose-Monterey, Los Angeles, Alaska Native Registry,
Rural Georgia, California excluding SF/SJM/LA,
Kentucky, Louisiana, and New Jersey) along with U.S.
Mortality Files, National Center for Health
Statistics, Centers for Disease Control (CDC) and
Prevention. Rates are expressed as per 100,000
and are age-adjusted to the 2000 US Std. Population,
using 19 age groups [Census P25-1003]. Rates for
American Indian/Alaska Native were based on the
CHSDA (Contract Health Service Deliver Area)
counties. Hispanic is noted not to be mutually
exclusive from whites, blacks, Asian/Pacific
Islanders, and American Indians/Alaska Natives.
The data for Hispanics were based on NHIA and
excluded cases from the Alaska Native Registry and
Kentucky. Mortality data for Hispanics
excluded cases from Minnesota, New Hampshire, and
North Dakota.
|